; (C) disseminating and improving the use of evidence-based opioid prescribing guidelines across relevant health care settings, as appropriate, and updating guidelines as necessary; (D) implementing strategies, such as best practices, to encourage and facilitate the use of prescriber guidelines, in accordance with State and local law; and (E) disseminating information to providers about prescribing options for controlled substances, including such options under section 309(f) of the Controlled Substances Act, as applicable; and (4) other appropriate entities. ; and (2) in subsection (b)— (A) by striking opioid abuse each place such term appears and inserting opioid misuse and abuse ; and (B) in paragraph (2), by striking safe disposal of prescription medications and other and inserting non-addictive or non-opioid treatment options, safe disposal options for prescription medications, and other applicable . 504. Enhanced controlled substance overdoses data collection, analysis, and dissemination Part J of title III of the Public Health Service Act is amended by inserting after section 392 ( 42 U.S.C. 280b–1 ) the following: 392A. Enhanced controlled substance overdoses data collection, analysis, and dissemination (a) In general The Director of the Centers for Disease Control and Prevention, using the authority provided to the Director under section 392, may— (1) to the extent practicable, carry out and expand any controlled substance overdose data collection, analysis, and dissemination activity described in subsection (b); (2) provide training and technical assistance to States, localities, and Indian tribes for the purpose of carrying out any such activity